School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Arezou Khosroshahi

  • Department of Medicine
    Associate Professor
  • akhosroshahi@emory.edu
Head shot of Arezou Khosroshahi

Overview

Dr. Arezou Khosroshahi received her medical degree from Tehran University Medical School in Iran. After finishing a postdoctoral research fellowship in the Transplantation Center at the Brigham and Womens Hospital, Harvard Medical School, she completed her internal medicine training at St. Lukes-Roosevelt Hospital Center, Columbia University. Upon completion of her clinical rheumatology fellowship at Massachusetts General Hospital, she became involved in exciting clinical research focused on a newly recognized condition called IgG4-related disease (IgG4-RD). Their group was one of the first in the country to become aware of and focus on this condition.

Dr. Khosroshahis efforts to understand different aspects of IgG4-RD over the past ten years have led to important contributions to the field of IgG4-RD, including adding new clinical manifestations to the list of organs involved with this protean disease and its responsiveness to B cell depletion. She co-directed the first two international symposiums on IgG4-RD to bring investigators from all around the world together and helped to establish the name of the disease, pathology statements for the diagnosis of this condition, and guidelines on the management of IgG4-RD. She is currently an active member of an international committee for the development of classification criteria and validation of IgG4-RD responder index.

Dr. Khosroshahi has established an IgG4-RD clinic at Emory since her arrival in 2013. This clinic is one of the few in the United States to evaluate and treat patients with IgG4-RD. Patients have the option to participate in multiple research projects related to this condition. She has developed close collaboration between clinicians in multiple specialties at Emory and scientists in Emorys Lowance Immunology Center to be able to diagnose, treat, and investigate many unknowns in regards to this novel condition.

She has been involved in Lupus Clinic at Grady Hospital for the past six years and recently established a new lupus clinic at Emory. She is the principal investigator for different clinical trials in lupus and is working closely with her colleagues Drs. Lim and Sanz to help understand many different aspects of lupus, with particular interest in treatment.

Dr. Khosroshahi has a particular interest in clinical education and works closely with Emory medical students, residents, and fellows at Grady Memorial Hospital and Emory University.

Academic Appointment

  • Associate Professor of Medicine, Emory University School of Medicine

Education

Degrees

  • MD from Tehran University of Medical Sciences

Research

Publications

  • Renal arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis.
    Rheumatology (Oxford) Volume: 64 Page(s): 2665 - 2675
    05/01/2025 Authors: Garg S; Astor BC; Lim SS; Raval AN; Zhong W; Panzer SE; Khosroshahi A; Rovin B; Bartels CM
  • Inebilizumab for Treatment of IgG4-Related Disease.
    N Engl J Med Volume: 392 Page(s): 1168 - 1177
    03/27/2025 Authors: Stone JH; Khosroshahi A; Zhang W; Della Torre E; Okazaki K; Tanaka Y; Lhr JM; Schleinitz N; Dong L; Umehara H
  • Unlocking disease insights to facilitate drug development: Pharmaceutical industry-academia collaborations in inflammation and immunology.
    Drug Discov Today Volume: 30 Page(s): 104317
    03/01/2025 Authors: Peeva E; Guttman-Yassky E; Yamaguchi Y; Berman B; Oemar B; Ramakrishna J; Fasano A; Evans-Molina C; Chu M; Ungar B
  • Multi-centered clinical validation demonstrating superior precision in lupus diagnosis: T cell autoantibodies and TC4d outperform conventional lupus erythematosus biomarkers.
    Front Immunol Volume: 16 Page(s): 1518208
    01/01/2025 Authors: Kyttaris V; Wallace DJ; Khosroshahi A; Concoff A; Wilson N; Liu CC; Manzi S; Ahearn J; Taghavi S; Warsi T
  • Publisher Correction: Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE.
    Nat Immunol Volume: 26 Page(s): 148
    01/01/2025 Authors: Faliti CE; Van TTP; Anam FA; Cheedarla N; Williams ME; Mishra AK; Usman SY; Woodruff MC; Kraker G; Runnstrom MC
  • Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLE.
    Nat Immunol Volume: 26 Page(s): 131 - 145
    01/01/2025 Authors: Faliti CE; Van TTP; Anam FA; Cheedarla N; Williams ME; Mishra AK; Usman SY; Woodruff MC; Kraker G; Runnstrom MC
  • Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta-analysis and Systematic Review.
    Arthritis Care Res (Hoboken) Volume: 76 Page(s): 1232 - 1245
    09/01/2024 Authors: Garg S; Sweet N; Boderman B; Montes D; Walunas T; Ramsey-Goldman R; Khosroshahi A; Astor BC; Lim SS; Bartels CM
  • Associations between TCA cycle plasma metabolites and fatigue in black females with systemic lupus erythematosus: An untargeted metabolomics pilot study.
    Lupus Volume: 33 Page(s): 948 - 961
    08/01/2024 Authors: Kimble LP; Khosroshahi A; Brewster GS; Dunbar SB; Ryan D; Carlson N; Eldridge R; Houser M; Corwin E
  • Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.
    JCI Insight Volume: 9
    06/04/2024 Authors: Anderson E; Powell M; Yang E; Kar A; Leung TM; Sison C; Steinberg R; Mims R; Choudhury A; Espinosa C
  • Distinct transcriptomes and autocrine cytokines underpin maturation and survival of antibody-secreting cells in systemic lupus erythematosus.
    Nat Commun Volume: 15 Page(s): 1899
    03/01/2024 Authors: Chen W; Hong S-H; Jenks SA; Anam FA; Tipton CM; Woodruff MC; Hom JR; Cashman KS; Faliti CE; Wang X
  • Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicity.
    Ann Rheum Dis Volume: 83 Page(s): 404 - 406
    02/15/2024 Authors: Yelnik CM; Xie X; Guerra MM; Costedoat-Chalumeau N; Khosroshahi A; Kamen DL; Schwartz N; Katz P; Minett M; Amoss RT
  • Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.
    Arthritis Rheumatol Volume: 75 Page(s): 2185 - 2194
    12/01/2023 Authors: Merrill JT; Guthridge J; Smith M; June J; Koumpouras F; Machua W; Askanase A; Khosroshahi A; Sheikh SZ; Rathi G
  • Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
    Rheumatol Ther Volume: 10 Page(s): 1795 - 1808
    12/01/2023 Authors: Perugino C; Culver EL; Khosroshahi A; Zhang W; Della-Torre E; Okazaki K; Tanaka Y; Lhr M; Schleinitz N; Falloon J
  • Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID.
    Nat Commun Volume: 14 Page(s): 4201
    07/14/2023 Authors: Woodruff MC; Bonham KS; Anam FA; Walker TA; Faliti CE; Ishii Y; Kaminski CY; Ruunstrom MC; Cooper KR; Truong AD
  • Performance of Modified ALMS and BLISS Criteria with Standard of Care Treatment in Two US Health Care Systems.
    Arthritis Care Res (Hoboken) Volume: 75 Page(s): 1423 - 1433
    07/01/2023 Authors: Khosroshahi A; Tong D; Bao G; Al-Naqeeb J; Ghosh P; Peeva E; Easley KA; Weiss R; Lim SS
  • SLE Antibody-Secreting Cells Are Characterized by Enhanced Peripheral Maturation and Survival Programs.
    Res Sq
    06/27/2023 Authors: Chen W; Hong S-H; Jenks SA; Anam FA; Tipton CM; Woodruff MC; Hom JR; Cashman KS; Faliti CE; Wang X
  • Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment.
    medRxiv
    06/12/2023 Authors: Faliti CE; Anam FA; Cheedarla N; Woodruff MC; Usman SY; Runnstrom MC; Van TTP; Kyu S; Ahmed H; Morrison-Porter A
  • Clinical Characteristics and Classification Criteria Performance in a Single-Center Cohort of 114 Patients With Immunoglobulin G4-Related Disease.
    J Clin Rheumatol Volume: 29 Page(s): 23 - 28
    01/01/2023 Authors: Spandorfer R; Ahmad M; Khosroshahi A
  • Dysregulated naive B cells and de novo autoreactivity in severe COVID-19.
    Nature Volume: 611 Page(s): 139 - 147
    11/01/2022 Authors: Woodruff MC; Ramonell RP; Haddad NS; Anam FA; Rudolph ME; Walker TA; Truong AD; Dixit AN; Han JE; Cabrera-Mora M
  • Diagnostic and Therapeutic Challenges.
    Retina Volume: 42 Page(s): 2018 - 2023
    10/01/2022 Authors: Wang G; Guan W; Peng X; Yeh S; Rishi P; Khosroshahi A
  • Recurrent Pleural Effusions, Lymphedema, and Abnormal Nails in a 61-Year-Old Man.
    Arthritis Care Res (Hoboken) Volume: 74 Page(s): 709 - 715
    05/01/2022 Authors: Amratia A; Ahmad M; Khosroshahi A
  • Mimickers of Immunoglobulin G4-Related Disease.
    Volume: 28 Page(s): e647 - e650
    03/01/2022 Authors: Ahmad M; Spandorfer R; Al Naqeeb J; Khosroshahi A
  • Error in the Title of the Article by Lee et al (Arthritis Care Res, December 2010), Error in Conclusion for the Article by Beltai et al (Arthritis Care Res, December 2018).
    Arthritis Care Res (Hoboken) Volume: 74 Page(s): 88
    01/01/2022
  • Multisystem inflammatory syndrome in an adult with involvement of the skin, lymph nodes, muscle, heart, liver and kidneys.
    Rheumatology (Oxford) Volume: 60 Page(s): e392 - e394
    11/03/2021 Authors: Kinter CW; Saxon GE; Ahmad M; Berhane H; Gensler L; Khosroshahi A
  • Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
    Ann Rheum Dis Volume: 80 Page(s): 1137 - 1146
    09/01/2021 Authors: Sparks JA; Wallace ZS; Seet AM; Gianfrancesco MA; Izadi Z; Hyrich KL; Strangfeld A; Gossec L; Carmona L; Mateus EF
  • Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy.
    Volume: 30 Page(s): 1509 - 1514
    08/01/2021 Authors: Sen M; Kurl A; Khosroshahi A
  • Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
    Clin Rheumatol Volume: 40 Page(s): 2633 - 2642
    07/01/2021 Authors: Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A
  • ANTI-MELANANOMA DIFFERENTIATION ASSOCIATED GENE 5 (MDA5) DERMATOMYSITIS: CLINICAL FEATURES AND OUTCOMES IN A PRE-DOMINANTLY AFRICAN-AMERICAN CASE SERIES
    Volume: 36 Page(s): S14 - S14
    07/01/2021 Authors: Wang DS; Khosroshahi A; Gandiga P
  • Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.
    Pediatr Rheumatol Online J Volume: 19 Page(s): 94
    06/21/2021 Authors: Villacis-Nunez DS; Rostad CA; Rouster-Stevens K; Khosroshahi A; Chandrakasan S; Prahalad S
  • METABOLOMIC PROFILING AND SYMPTOM BURDEN IN BLACK WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Volume: 80 Page(s): 299 - 300
    06/01/2021 Authors: Kimble LP; Khosroshahi A; Eldridge RC; Brewster GS; Carlson NS; Corwin EJ
  • A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).
    Volume: 38
    05/20/2020 Authors: Dumbrava EEI; Suarez-Almazor ME; Painter J; Johanns T; Dougan ML; Cappelli L; Bingham CO; Wang Y; Gupta S; Warner BM
  • Cardiovascular Disease Burden Among In-patients With Systemic Lupus Erythematosus
    Volume: 141
    03/03/2020 Authors: Kimble LP; Dunbar SB; Corwin EJ; Mitchell R; Sanz I; Khosroshahi A
  • The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
    Ann Rheum Dis Volume: 79 Page(s): 77 - 87
    01/01/2020 Authors: Wallace ZS; Naden RP; Chari S; Choi HK; Della-Torre E; Dicaire J-F; Hart PA; Inoue D; Kawano M; Khosroshahi A
  • The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
    Arthritis Rheumatol Volume: 72 Page(s): 7 - 19
    01/01/2020 Authors: Wallace ZS; Naden RP; Chari S; Choi H; Della-Torre E; Dicaire J-F; Hart PA; Inoue D; Kawano M; Khosroshahi A
  • Epigenetic programming underpins B cell dysfunction in human SLE.
    Nat Immunol Volume: 20 Page(s): 1071 - 1082
    08/01/2019 Authors: Scharer CD; Blalock EL; Mi T; Barwick BG; Jenks SA; Deguchi T; Cashman KS; Neary BE; Patterson DG; Hicks SL
  • IgG4-Related Disease with Emphasis on Its Gastrointestinal Manifestation.
    Gastroenterol Clin North Am Volume: 48 Page(s): 291 - 305
    06/01/2019 Authors: Vashi B; Khosroshahi A
  • Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts.
    Ann Rheum Dis Volume: 78 Page(s): 406 - 412
    03/01/2019 Authors: Wallace ZS; Zhang Y; Perugino CA; Naden R; Choi HK; Stone JH; ACR/EULAR IgG4-RD Classification Criteria Committee
  • Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE.
    Lupus Sci Med Volume: 6 Page(s): e000349
    01/01/2019 Authors: Wallace DJ; Alexander RV; O'Malley T; Khosroshahi A; Hojjati M; Loupasakis K; Alper J; Sherrer Y; Fondal M; Kataria R
  • An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index.
    Volume: 70 Page(s): 1671 - 1678
    11/01/2018 Authors: Wallace ZS; Khosroshahi A; Carruthers MD; Perugino CA; Choi H; Campochiaro C; Culver EL; Cortazar F; Della-Torre E; Ebbo M
  • A RARE ASTHMA MIMIC
    Volume: 154 Page(s): 11A - 11A
    10/01/2018 Authors: Wynn A; Veeraraghavan S; Khosroshahi A
  • A 55-Year-Old Male Presenting With Altered Mental Status: A Complicated Case of Intracranial Aneurysm.
    Arthritis Care Res (Hoboken) Volume: 69 Page(s): 1915 - 1919
    12/01/2017 Authors: Garg S; Khosroshahi A
  • Diagnostic and treatment workup for IgG4-related disease.
    Expert Rev Clin Immunol Volume: 13 Page(s): 867 - 875
    09/01/2017 Authors: Abraham M; Khosroshahi A
  • CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 34-2015. A 36-Year-Old Woman with a Lung Mass, Pleural Effusion, and Hip Pain.
    N Engl J Med Volume: 373 Page(s): 1762 - 1772
    10/29/2015 Authors: Khosroshahi A; Digumarthy SR; Gibbons FK; Deshpande V
  • Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4years' by Yamamoto et al.
    Ann Rheum Dis Volume: 74 Page(s): e47
    08/01/2015 Authors: Stone JH; Carruthers MN; Topazian MD; Khosroshahi A; Witzig TE; Wallace ZS; Hart PA; Deshpande V; Smyrk TC; Chari S
  • Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years.
    Ann Rheum Dis Volume: 74 Page(s): e46
    08/01/2015 Authors: Yamamoto M; Awakawa T; Takahashi H
  • International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.
    Arthritis Rheumatol Volume: 67 Page(s): 1688 - 1699
    07/01/2015 Authors: Khosroshahi A; Wallace ZS; Crowe JL; Akamizu T; Azumi A; Carruthers MN; Chari ST; Della-Torre E; Frulloni L; Goto H
  • Rituximab for IgG4-related disease: a prospective, open-label trial.
    Ann Rheum Dis Volume: 74 Page(s): 1171 - 1177
    06/01/2015 Authors: Carruthers MN; Topazian MD; Khosroshahi A; Witzig TE; Wallace ZS; Hart PA; Deshpande V; Smyrk TC; Chari S; Stone JH
  • The diagnostic utility of serum IgG4 concentrations in IgG4-related disease.
    Ann Rheum Dis Volume: 74 Page(s): 14 - 18
    01/01/2015 Authors: Carruthers MN; Khosroshahi A; Augustin T; Deshpande V; Stone JH
  • Reply: To PMID 24431286.
    Arthritis Rheumatol Volume: 66 Page(s): 3247 - 3248
    11/01/2014 Authors: Khosroshahi A; Cheryk LA; Bloch DB; Stone JH
  • Reply: To PMID 24431286.
    Arthritis Rheumatol Volume: 66 Page(s): 1965 - 1966
    07/01/2014 Authors: Stone JH; Khosroshahi A
  • Abundance of IGG4-Positive Plasma Cells in Post-Neoadjuvant Ulcers of Gastroesophageal Carcinomas
    Volume: 27 Page(s): 174A - 174A
    02/01/2014 Authors: Genco I; Saka B; Balci S; Bradley K; Farris AB; Khosroshahi A; El-Rayes B; Krasinskas A; Staley C; Kooby D
  • Increased IgG4+Plasma Cells and IgG4/IgG Ratio May Be Seen in Lymph Nodes from Patients without IgG4-Related Disease
    Volume: 94 Page(s): 353A - 353A
    02/01/2014 Authors: Husman A; Khosroshahi A; Cohen C; Bradley K
  • Increased IgG4+Plasma Cells and IgG4/IgG Ratio May Be Seen in Lymph Nodes from Patients without IgG4-Related Disease
    Volume: 27 Page(s): 353A - 353A
    02/01/2014 Authors: Husman A; Khosroshahi A; Cohen C; Bradley K
  • Abundance of IGG4-Positive Plasma Cells in Post-Neoadjuvant Ulcers of Gastroesophageal Carcinomas
    Volume: 94 Page(s): 174A - 174A
    02/01/2014 Authors: Genco I; Saka B; Balci S; Bradley K; Farris AB; Khosroshahi A; El-Rayes B; Krasinskas A; Staley C; Kooby D
  • Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease.
    Arthritis Rheumatol Volume: 66 Page(s): 213 - 217
    01/01/2014 Authors: Khosroshahi A; Cheryk LA; Carruthers MN; Edwards JA; Bloch DB; Stone JH
  • Rituximab For The Treatment Of IgG4-Related Disease: A Prospective Clinical Trial
    Volume: 65 Page(s): S1128 - S1129
    10/01/2013 Authors: Carruthers M; Topazian M; Khosroshahi A; Witzig T; Oakley J; Hart P; Kelly L; Bergstrom L; Chari S; Stone J
  • IgG4-related disease and hypertrophic pachymeningitis.
    Medicine (Baltimore) Volume: 92 Page(s): 206 - 216
    07/01/2013 Authors: Wallace ZS; Carruthers MN; Khosroshahi A; Carruthers R; Shinagare S; Stemmer-Rachamimov A; Deshpande V; Stone JH
  • Does autoimmune pancreatitis increase the risk of pancreatic carcinoma?: a retrospective analysis of pancreatic resections.
    Pancreas Volume: 42 Page(s): 506 - 510
    04/01/2013 Authors: Gupta R; Khosroshahi A; Shinagare S; Fernandez C; Ferrone C; Lauwers GY; Stone JH; Deshpande V
  • Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease.
    Medicine (Baltimore) Volume: 92 Page(s): 82 - 91
    03/01/2013 Authors: Khosroshahi A; Carruthers MN; Stone JH; Shinagare S; Sainani N; Hasserjian RP; Deshpande V
  • Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Arthritis Care Res (Hoboken) Volume: 64 Page(s): 1720 - 1729
    11/01/2012 Authors: Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
  • Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.
    Arthritis Rheum Volume: 64 Page(s): 3061 - 3067
    10/01/2012 Authors: Stone JH; Khosroshahi A; Deshpande V; Chan JKC; Heathcote JG; Aalberse R; Azumi A; Bloch DB; Brugge WR; Carruthers MN
  • Depletion of CD4-Effector Memory T Cells and Clonally Expanded IgG4 Memory B Cells May Explain the Therapeutic Efficacy of Rituximab in IgG4-Related Disease: Studies Using Flow Cytometry and Single-Cell Sequencing
    Volume: 64 Page(s): S750 - S750
    10/01/2012 Authors: Mattoo H; Khosroshahi A; Mahajan V; Carruthers M; Stone J; Pillai S
  • Hypertrophic Pachymeningitis: IgG4-Related Disease Is A Common Etiology.
    Volume: 64 Page(s): S1067 - S1068
    10/01/2012 Authors: Wallace ZS; Carruthers M; Khosroshahi A; Carruthers R; Shinagare S; Stemmer-Rachamimov A; Deshpande V; Stone JH
  • IgG4 Plasma Cell Infiltration in Granulomatosis with Polyangiitis (formerly Wegener's) Lung Biopsies.
    Volume: 64 Page(s): S656 - S657
    10/01/2012 Authors: Carruthers M; Shinagare S; Khosroshahi A; Deshpande V; Stone JH
  • Prozone Phenomenon Leads to Low IgG4 Concentrations in IgG4-Related Disease.
    Volume: 64 Page(s): S1067 - S1067
    10/01/2012 Authors: Khosroshahi A; Cheryk LA; Carruthers M; Edwards JA; Bloch DB; Stone JH
  • Utility of PET-CT Imaging in IgG4-Related Disease
    Volume: 64 Page(s): S58 - S58
    10/01/2012 Authors: Khosroshahi A; Lee L; Carruthers M; Acu R; Bonaffini P; Deshpande V; Sahani D; Stone JH
  • Consensus statement on the pathology of IgG4-related disease.
    Mod Pathol Volume: 25 Page(s): 1181 - 1192
    09/01/2012 Authors: Deshpande V; Zen Y; Chan JK; Yi EE; Sato Y; Yoshino T; Klppel G; Heathcote JG; Khosroshahi A; Ferry JA
  • IgG4-related disease presenting as recurrent mastoiditis.
    Laryngoscope Volume: 122 Page(s): 681 - 684
    03/01/2012 Authors: Schiffenbauer AI; Wahl C; Pittaluga S; Jaffe ES; Hoffman R; Khosroshahi A; Stone JH; Deshpande V; Gahl WA; Gill F
  • Bone Marrow Manifestations of IgG4-Related Disease
    Volume: 92 Page(s): 370A - 371A
    02/01/2012 Authors: Sohani AR; Mahindra A; Khosroshahi A; Stone JH; Deshpande V; Hasserjian RP
  • Clinicopathologic Features of IgG4-Associated Retroperitoneal Fibrosis
    Volume: 92 Page(s): 16A - 16A
    02/01/2012 Authors: Lew M; Carruthers M; Khosroshahi A; Hasserjian R; Stone JH; Nielsen GP; Deshpande V
  • Bone Marrow Manifestations of IgG4-Related Disease
    Volume: 25 Page(s): 370A - 371A
    02/01/2012 Authors: Sohani AR; Mahindra A; Khosroshahi A; Stone JH; Deshpande V; Hasserjian RP
  • Clinicopathologic Features of IgG4-Associated Retroperitoneal Fibrosis
    Volume: 25 Page(s): 16A - 16A
    02/01/2012 Authors: Lew M; Carruthers M; Khosroshahi A; Hasserjian R; Stone JH; Nielsen GP; Deshpande V
  • The latest on IgG4-RD: a rapidly emerging disease.
    Curr Opin Rheumatol Volume: 24 Page(s): 60 - 69
    01/01/2012 Authors: Carruthers MN; Stone JH; Khosroshahi A
  • Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
    Medicine (Baltimore) Volume: 91 Page(s): 57 - 66
    01/01/2012 Authors: Khosroshahi A; Carruthers MN; Deshpande V; Unizony S; Bloch DB; Stone JH
  • IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement.
    Surv Ophthalmol Volume: 57 Page(s): 26 - 33
    01/01/2012 Authors: Wallace ZS; Khosroshahi A; Jakobiec FA; Deshpande V; Hatton MP; Ritter J; Ferry JA; Stone JH
  • Development of an IgG4-RD Responder Index.
    Int J Rheumatol Volume: 2012 Page(s): 259408
    01/01/2012 Authors: Carruthers MN; Stone JH; Deshpande V; Khosroshahi A
  • IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor.
    Int J Rheumatol Volume: 2012 Page(s): 139409
    01/01/2012 Authors: Khosroshahi A; Ayalon R; Beck LH; Salant DJ; Bloch DB; Stone JH
  • The Clinical and Pathological Features of IgG(4)-Related Disease.
    Curr Rheumatol Rep Volume: 13 Page(s): 473 - 481
    12/01/2011 Authors: Khosroshahi A; Deshpande V; Stone JH
  • Tocilizumab for the Treatment of Large Vessel Vasculitis (Giant Cell Arteritis, Takayasu Arteritis) and Polymyalgia Rheumatica: A Case Series.
    Volume: 63 Page(s): S589 - S589
    10/01/2011 Authors: Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar SL; Khosroshahi A; Stone JH
  • Rituximab for the Treatment of IgG4-Related Disease: Lessons From Ten Consecutive Patients
    Volume: 63 Page(s): S683 - S683
    10/01/2011 Authors: Khosroshahi A; Carruthers M; Deshpande V; Unizony S; Bloch DB; Stone JH
  • Cutaneous immunoglobulin G4-related systemic disease.
    Am J Med Volume: 124 Page(s): e7 - e8
    10/01/2011 Authors: Khosroshahi A; Carruthers MD; Deshpande V; Leb L; Reed JI; Stone JH
  • A Clinicopathologic Study of Retroperitoneal Fibrosis and Its Association with Immunoglobulin G4-Related Disease
    Volume: 63 Page(s): S672 - S672
    10/01/2011 Authors: Khosroshahi A; Hasserjian RP; Sainani NI; Deshpande V; Stone JH
  • Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease.
    Am J Surg Pathol Volume: 35 Page(s): 701 - 706
    05/01/2011 Authors: Deshpande V; Khosroshahi A; Nielsen GP; Hamilos DL; Stone JH
  • A clinical overview of IgG4-related systemic disease.
    Curr Opin Rheumatol Volume: 23 Page(s): 57 - 66
    01/01/2011 Authors: Khosroshahi A; Stone JH
  • Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
    Am J Surg Pathol Volume: 35 Page(s): 26 - 35
    01/01/2011 Authors: Deshpande V; Gupta R; Sainani N; Sahani DV; Virk R; Ferrone C; Khosroshahi A; Stone JH; Lauwers GY
  • IgG4-related systemic disease: the age of discovery.
    Curr Opin Rheumatol Volume: 23 Page(s): 72 - 73
    01/01/2011 Authors: Khosroshahi A; Stone JH
  • A 22-year-old woman with severe headaches, vomiting, and tonic-clonic seizures.
    Arthritis Care Res (Hoboken) Volume: 63 Page(s): 165 - 171
    01/01/2011 Authors: Dahlgren M; Khosroshahi A; Stone JH
  • Treatment approaches to IgG4-related systemic disease.
    Curr Opin Rheumatol Volume: 23 Page(s): 67 - 71
    01/01/2011 Authors: Khosroshahi A; Stone JH
  • A 44-year-old woman with cutaneous bullae and extensive skin necrosis.
    Arthritis Care Res (Hoboken) Volume: 62 Page(s): 1805 - 1811
    12/01/2010 Authors: Lee BL; Stone JH; Gimbel D; Khosroshahi A
  • Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum.
    Arthritis Care Res (Hoboken) Volume: 62 Page(s): 1312 - 1318
    09/01/2010 Authors: Dahlgren M; Khosroshahi A; Nielsen GP; Deshpande V; Stone JH
  • Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.
    Arthritis Rheum Volume: 62 Page(s): 1755 - 1762
    06/01/2010 Authors: Khosroshahi A; Bloch DB; Deshpande V; Stone JH
  • IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases.
    Arthritis Care Res (Hoboken) Volume: 62 Page(s): 316 - 322
    03/01/2010 Authors: Stone JH; Khosroshahi A; Deshpande V; Stone JR
  • Thoracic Lymphoplasmacytic Aortitis Is Often Associated with IgG4-Related Systemic Disease
    Volume: 23 Page(s): 84A - 84A
    02/01/2010 Authors: Stone JR; Khosroshahi A; Deshpande V; Stone JH
  • Thoracic Lymphoplasmacytic Aortitis Is Often Associated with IgG4-Related Systemic Disease
    Volume: 90 Page(s): 84A - 84A
    02/01/2010 Authors: Stone JR; Khosroshahi A; Deshpande V; Stone JH
  • IgG4-related systemic disease and lymphoplasmacytic aortitis.
    Arthritis Rheum Volume: 60 Page(s): 3139 - 3145
    10/01/2009 Authors: Stone JH; Khosroshahi A; Hilgenberg A; Spooner A; Isselbacher EM; Stone JR
  • Painless jaundice with serial multi-organ dysfunction.
    Lancet Volume: 373 Page(s): 1494
    04/25/2009 Authors: Khosroshahi A; Stone JR; Pratt DS; Deshpande V; Stone JH
  • Differential role of programmed death-1 ligand and programmed death-2 ligand in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis (vol 176, pg 3480, 2006)
    JOURNAL OF IMMUNOLOGY Volume: 176 Page(s): 5683 - 5683
    05/01/2006 Authors: Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma A; Yagita H; Sayegh MH; Khoury SJ
  • Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
    J Immunol Volume: 176 Page(s): 3480 - 3489
    03/15/2006 Authors: Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ
  • PDL1 regulates autoimmunity by limiting expansion of autoreactive Th1 cells and mediates resistance to diabetes in NOD mice.
    Volume: 119 Page(s): S168 - S168
    01/01/2006 Authors: Guleria I; Dada S; Eckenrode S; Bupp MG; Ansari M; Vadivel N; Trikudanathan S; Fiorina P; Khosroshahi A; Yagita H
  • A critical role for the programmed death ligand 1 in fetomaternal tolerance.
    J Exp Med Volume: 202 Page(s): 231 - 237
    07/18/2005 Authors: Guleria I; Khosroshahi A; Ansari MJ; Habicht A; Azuma M; Yagita H; Noelle RJ; Coyle A; Mellor AL; Khoury SJ
  • Mechanisms of fetomaternal tolerance: Critical role of negative costimulatory pathways.
    Volume: 5 Page(s): 383 - 383
    05/01/2005 Authors: Guleria I; Khosroshahi A; Habicht A; Duda S; Ansari MJ; Azuma M; Mellor AL; Khoury S; Sayeg M
  • The programmed death-1 (PD1) negative costimulatory pathway plays a critical role in fetomaternal tolerance.
    Volume: 4 Page(s): 187 - 187
    01/01/2004 Authors: Guleria I; Khosroshahi A; Imitola J; Ansari MJ; Azuma M; Khoury SJ; Sayegh MH
  • Marked prolongation of islet allograft survival in NOD mice with high dose rapamycin and CD154 plus ICOSL blockade.
    Volume: 4 Page(s): 467 - 467
    01/01/2004 Authors: Ansari MJI; Khosroshahi A; Guleria I; Yagita H; Auchincloss H; Sayegh MH
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements